BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27553263)

  • 1. Film-forming formulations containing porous silica for the sustained delivery of actives to the skin.
    Heck R; Hermann S; Lunter DJ; Daniels R
    Eur J Pharm Biopharm; 2016 Nov; 108():1-8. PubMed ID: 27553263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo skin permeation and penetration of nonivamide from and in vivo skin tolerability of film-forming formulations containing porous silica.
    Heck R; Lukić MŽ; Savić SD; Daniels R; Lunter DJ
    Eur J Pharm Sci; 2017 Aug; 106():34-40. PubMed ID: 28546105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro skin permeation and penetration of nonivamide from novel film-forming emulsions.
    Lunter D; Daniels R
    Skin Pharmacol Physiol; 2013; 26(3):139-46. PubMed ID: 23549242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies on release and skin permeation of nonivamide from novel oil-in-oil-emulsions.
    Rottke M; Lunter DJ; Daniels R
    Eur J Pharm Biopharm; 2014 Feb; 86(2):260-6. PubMed ID: 24095781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for the determination of the substantivity of topical formulations.
    Herrmann S; Daniels R; Lunter D
    Pharm Dev Technol; 2017 Jun; 22(4):487-491. PubMed ID: 26754018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New film forming emulsions containing Eudragit® NE and/or RS 30D for sustained dermal delivery of nonivamide.
    Lunter DJ; Daniels R
    Eur J Pharm Biopharm; 2012 Oct; 82(2):291-8. PubMed ID: 22750130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Method to determine the impact of substantivity on ex vivo skin-permeation.
    Schmidberger M; Daniels R; Lunter DJ
    Eur J Pharm Biopharm; 2018 Oct; 131():1-7. PubMed ID: 30048744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Submicron polymeric particles prepared by vibrational spray-drying: Semisolid formulation and skin penetration/permeation studies.
    Beber TC; Andrade DF; Kann B; Fontana MC; Coradini K; Windbergs M; Beck RC
    Eur J Pharm Biopharm; 2014 Nov; 88(3):602-13. PubMed ID: 25078859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
    Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of film-forming gel containing nanoparticles for transdermal drug delivery.
    Ngo HV; Tran PHL; Lee BJ; Tran TTD
    Nanotechnology; 2019 Oct; 30(41):415102. PubMed ID: 31261146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical elucidation of the mechanism of enhanced drug release and topical delivery from polymeric film-forming systems.
    Garvie-Cook H; Frederiksen K; Petersson K; Guy RH; Gordeev SN
    J Control Release; 2015 Aug; 212():103-12. PubMed ID: 26087467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation considerations in the design of topical, polymeric film-forming systems for sustained drug delivery to the skin.
    Frederiksen K; Guy RH; Petersson K
    Eur J Pharm Biopharm; 2015 Apr; 91():9-15. PubMed ID: 25595740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oil-in-oil-emulsions with enhanced substantivity for the treatment of chronic skin diseases.
    Lunter DJ; Rottke M; Daniels R
    J Pharm Sci; 2014 May; 103(5):1515-9. PubMed ID: 24634106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization.
    Rastogi V; Yadav P; Husain A; Verma A
    Drug Dev Ind Pharm; 2019 Apr; 45(4):669-682. PubMed ID: 30633579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of water-soluble polyvinyl alcohol-based film patches on laser microporated skin facilitates intradermal macromolecule and nanoparticle delivery.
    Engelke L; Winter G; Engert J
    Eur J Pharm Biopharm; 2018 Jul; 128():119-130. PubMed ID: 29660407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric nanoparticles modified with fatty acids encapsulating betamethasone for anti-inflammatory treatment.
    Silva CO; Rijo P; Molpeceres J; Figueiredo IV; Ascensão L; Fernandes AS; Roberto A; Reis CP
    Int J Pharm; 2015 Sep; 493(1-2):271-84. PubMed ID: 26222745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of ethinylestradiol from film forming polymeric solutions across human epidermis in vitro and in vivo in pigs.
    Zurdo Schroeder I; Franke P; Schaefer UF; Lehr CM
    J Control Release; 2007 Apr; 118(2):196-203. PubMed ID: 17289207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intradermal and follicular delivery of adapalene liposomes.
    Kumar V; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):871-9. PubMed ID: 27031916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Approach to Ex Vivo Permeation Studies in In-Situ Film-Forming Systems.
    Silva-Alvarez AF; Ferreira MP; Vicentini FTMC; Pedrazzi V; de Freitas O
    AAPS PharmSciTech; 2020 Sep; 21(7):257. PubMed ID: 32895787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.